SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,206.44 |
| Enterprise Value ($M) | 3,057.80 |
| Book Value ($M) | 927.92 |
| Book Value / Share | 12.30 |
| Price / Book | 3.46 |
| NCAV ($M) | 608.09 |
| NCAV / Share | 8.06 |
| Price / NCAV | 5.27 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.19 |
| Return on Assets (ROA) | -0.25 |
| Return on Equity (ROE) | -0.27 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 23.65 |
| Current Ratio | 23.65 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 644.96 |
| Assets | 964.80 |
| Liabilities | 36.88 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -214.05 |
| Net Income | -182.39 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -145.33 |
| Cash from Investing | -117.17 |
| Cash from Financing | 353.52 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Driehaus Capital Management Llc | 5.88 | -7.19 | |
| 13G/A | Avoro Capital Advisors LLC | 7.70 | 15.65 | |
| 13G/A | Fmr Llc | 7.56 | 20.57 | |
| 13G | Wellington Management Group Llp | 5.56 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 29,782 | 204,121 | 14.59 | |
| 50,205 | 117,092 | 42.88 | |
| 104,570 | 147,224 | 71.03 | |
| 197,753 | 145,334 | 136.07 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VNDA – Vanda Pharmaceuticals Inc. | VRCA – Verrica Pharmaceuticals Inc. |
| WVE – Wave Life Sciences Ltd. | XNCR – Xencor, Inc. |
| XOMA – XOMA Corporation |
Financial data and stock pages provided by
Fintel.io